{"entity":{"type":"insider","cik":"0001782805","url":"/insider/0001782805","json_url":"/insider/0001782805.json","name":"Mandelia Ashish","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":11,"first":"2020-07-06","last":"2025-01-17","span_basis":"filed_date"},"name_variants":[{"name":"Mandelia Ashish","source":"filing","n_filings":11,"first_seen":"2020-07-06","last_seen":"2025-01-17"}],"transactions":[{"id":5042967,"accession":"0001104659-25-004597","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-004597","line_url":"/filing/0001104659-25-004597#line-3","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3554.0,"shares_display":"3,554","price_per_share":0.58,"price_display":"0.58","price_state":"stated","total_value":2061.32,"total_display":"2,061.32","total_whole":"2,061","shares_owned_after":57519.0,"shares_owned_after_display":"57,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":4029629,"accession":"0001104659-25-004185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-004185","line_url":"/filing/0001104659-25-004185#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1791.0,"shares_display":"1,791","price_per_share":0.63,"price_display":"0.63","price_state":"stated","total_value":1128.33,"total_display":"1,128.33","total_whole":"1,128","shares_owned_after":52388.0,"shares_owned_after_display":"52,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-16","scope":"insider"},{"id":4347618,"accession":"0001104659-25-003879","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-003879","line_url":"/filing/0001104659-25-003879#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1007.0,"shares_display":"1,007","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":664.62,"total_display":"664.62","total_whole":"665","shares_owned_after":49396.0,"shares_owned_after_display":"49,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-14","filed_date":"2025-01-15","scope":"insider"},{"id":2998606,"accession":"0001104659-24-106748","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-106748","line_url":"/filing/0001104659-24-106748#line-3","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3361.0,"shares_display":"3,361","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":6587.56,"total_display":"6,587.56","total_whole":"6,588","shares_owned_after":47757.0,"shares_owned_after_display":"47,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-07","scope":"insider"},{"id":2998604,"accession":"0001104659-24-106748","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-106748","line_url":"/filing/0001104659-24-106748#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4855.0,"shares_display":"4,855","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":9710.0,"total_display":"9,710.00","total_whole":"9,710","shares_owned_after":51118.0,"shares_owned_after_display":"51,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-02","filed_date":"2024-10-07","scope":"insider"},{"id":2777937,"accession":"0001104659-24-004549","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-004549","line_url":"/filing/0001104659-24-004549#line-5","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5025.0,"shares_display":"5,025","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":13617.75,"total_display":"13,617.75","total_whole":"13,618","shares_owned_after":23328.0,"shares_owned_after_display":"23,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":7997525,"accession":"0001104659-23-004743","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-004743","line_url":"/filing/0001104659-23-004743#line-4","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Controller)","role_mark":"O","role_mark_label":"Officer (VP, Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3575.0,"shares_display":"3,575","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":20520.5,"total_display":"20,520.50","total_whole":"20,521","shares_owned_after":13619.0,"shares_owned_after_display":"13,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-18","scope":"insider"},{"id":6808884,"accession":"0001104659-22-005555","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-005555","line_url":"/filing/0001104659-22-005555#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Controller)","role_mark":"O","role_mark_label":"Officer (VP, Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1982.0,"shares_display":"1,982","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":11733.44,"total_display":"11,733.44","total_whole":"11,733","shares_owned_after":3371.0,"shares_owned_after_display":"3,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-19","scope":"insider"},{"id":5440976,"accession":"0001104659-21-088909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-088909","line_url":"/filing/0001104659-21-088909#line-1","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Controller)","role_mark":"O","role_mark_label":"Officer (VP, Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":942.0,"shares_display":"942","price_per_share":13.6,"price_display":"13.60","price_state":"stated","total_value":12811.2,"total_display":"12,811.20","total_whole":"12,811","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-02","scope":"insider"},{"id":4947578,"accession":"0001104659-21-005946","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-005946","line_url":"/filing/0001104659-21-005946#line-3","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Controller)","role_mark":"O","role_mark_label":"Officer (VP, Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":545.0,"shares_display":"545","price_per_share":21.28,"price_display":"21.28","price_state":"stated","total_value":11597.6,"total_display":"11,597.60","total_whole":"11,598","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-20","scope":"insider"},{"id":4719780,"accession":"0001104659-21-001643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-001643","line_url":"/filing/0001104659-21-001643#line-1","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Controller)","role_mark":"O","role_mark_label":"Officer (VP, Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":247.0,"shares_display":"247","price_per_share":26.76,"price_display":"26.76","price_state":"stated","total_value":6609.72,"total_display":"6,609.72","total_whole":"6,610","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider"},{"id":2563110,"accession":"0001104659-20-081224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-081224","line_url":"/filing/0001104659-20-081224#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Controller)","role_mark":"O","role_mark_label":"Officer (VP, Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3383.0,"shares_display":"3,383","price_per_share":22.49,"price_display":"22.49","price_state":"stated","total_value":76083.67,"total_display":"76,083.67","total_whole":"76,084","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-02","filed_date":"2020-07-06","scope":"insider"},{"id":2563107,"accession":"0001104659-20-081224","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-081224","line_url":"/filing/0001104659-20-081224#line-1","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001782805","owner_name":"Mandelia Ashish","owner_display_name":"Mandelia Ashish","owner_url":"/insider/0001782805","role":"Officer (VP, Controller)","role_mark":"O","role_mark_label":"Officer (VP, Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3383.0,"shares_display":"3,383","price_per_share":4.87,"price_display":"4.87","price_state":"stated","total_value":16475.21,"total_display":"16,475.21","total_whole":"16,475","shares_owned_after":3383.0,"shares_owned_after_display":"3,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001442836","name":"Mersana Therapeutics, Inc.","url":"/issuer/0001442836","role":"Officer (VP, Chief Accounting Officer)","n_filings":11,"first_seen":"2020-07-06","last_seen":"2025-01-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001782805","retrieved_at":"2026-08-23T08:47:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}